Greenwood business prepping for insulin boom

A biotechnology company has reached an agreement to make a drug for a large pharmaceutical company at the plant it’s build­ing in Greenwood.

Elona Biotech­nologies will make a generic drug for the unspecified drug company in addition to the lost-cost insulin it plans to manufacture in Greenwood. The second product will be a significant addition at the 50,000-square-foot manufacturing facility that’s now under construction, chief executive officer Ron Zimmerman Jr. said

Most importantly, a business arrangement with a major pharmaceutical company will give Elona validation, Zimmer­man said.

“This licensing deal pretty much proves to the world what we’ve been saying all along,” he said. “It’s our Good Housekeeping Seal of Approval. Everything should go quickly now that it’s in place.”

Elona would make the drug in Greenwood, and the large drug-maker would license and market it. Zimmerman said he wasn’t at liberty to discuss details, such as which company or what type of drug.

The full story is available to subscribers only.

Subscribers can read the entire story online by signing in here.

Not a subscriber? Become one today for as little as $11 by clicking here.

All content copyright ©2015 Daily Journal, a division of Home News Enterprises unless otherwise noted.
All rights reserved. Click here to read our privacy policy.